ONCO · Categories · Form 4
ONCO - SEC Form 4 insider transactions
Onconetix Inc. (ONCO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ONCO
- SEC Form 4 filed by Hrt Financial Lp4 - Onconetix, Inc. (0001782107) (Issuer)
- SEC Form 4 filed by Hrt Financial Lp4 - Onconetix, Inc. (0001782107) (Issuer)
- SEC Form 4 filed by Hrt Financial Lp4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Tarsh Simon acquired 39 shares and was granted 618 shares, increasing direct ownership by 65,700% to 658 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Meier Thomas acquired 39 shares and was granted 618 shares (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Oakley Andrew John acquired 20 shares and was granted 618 shares (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Ramdeen Timothy R. was granted 618 shares and acquired 39 shares, increasing direct ownership by 65,700% to 658 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Large owner Altos Venture Ag acquired 241,514 shares, increasing direct ownership by 761% to 273,230 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Oakley Andrew John was granted 1,709 shares (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Interim CEO, CSO Schiess Ralph was granted 177,462 shares, increasing direct ownership by 36% to 673,365 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Chief Strategy Officer Bruhlmann Christian was granted 177,462 shares, increasing direct ownership by 41% to 611,372 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Tarsh Simon was granted 3,318 shares, increasing direct ownership by 2,087% to 3,477 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Singh Ajit was granted 3,318 shares, increasing direct ownership by 4,254% to 3,396 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Sapirstein James was granted 3,318 shares, increasing direct ownership by 2,087% to 3,477 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Ramdeen Timothy R. was granted 3,318 shares, increasing direct ownership by 2,087% to 3,477 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Director Meier Thomas was granted 3,318 shares (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Interim CEO & CSO Schiess Ralph was granted 489,160 shares, increasing direct ownership by 7,254% to 495,903 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Chief Strategy Officer Bruhlmann Christian was granted 428,010 shares, increasing direct ownership by 7,254% to 433,910 units (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)
- Singh Ajit was granted 3,125 shares (SEC Form 4)4 - Onconetix, Inc. (0001782107) (Issuer)